Argenx Q2 Earnings, Revenue Rise-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Argenx Q2 Earnings, Revenue Rise

Jul 31, 2025 1:20 AM

04:05 AM EDT, 07/31/2025 (MT Newswires) -- Argenx (ARGX) reported Q2 earnings Thursday of $3.74 per diluted share, up from $0.45 a year earlier.

Analysts polled by FactSet expected $3.09.

Operating income for the quarter ended June 30 was $967.2 million, compared with $489.4 million a year earlier.

Analysts surveyed by FactSet expected $877.3 million.

Previous page： Cheniere Energy to expedite regulatory applications for LNG plants under Trump administration Next page： Boeing CEO Says Elon Musk Helping Resolve Bottlenecks for New Air Force One Fleet

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cheniere Energy to expedite regulatory applications for LNG plants under Trump administration

Feb 20, 2025

HOUSTON, Feb 20 (Reuters) - Cheniere Energy plans to aggressively pursue liquefied natural gas regulatory permits now that U.S. President Donald Trump is in office, thereby reducing regulatory risks for future growth, the company's CEO Jack Fusco said on Thursday. Cheniere plans to double its current LNG production to 90 million metric tonnes per annum (MTPA) by building more export...

Boeing CEO Says Elon Musk Helping Resolve Bottlenecks for New Air Force One Fleet

Feb 20, 2025

11:38 AM EST, 02/20/2025 (MT Newswires) -- Boeing ( BA ) Chief Executive Officer Kelly Ortberg said Elon Musk is helping the company resolve production bottlenecks for the new Air Force One fleet, according to a FactSet transcript Thursday. The president's clearly not happy with the delivery timing. I think he's made that well known. And Elon Musk is actually...

Incyte, Genesis Therapeutics Form AI-Centered Collaboration to Discover Small Molecule Medicines

Feb 20, 2025

11:34 AM EST, 02/20/2025 (MT Newswires) -- Incyte ( INCY ) and Genesis Therapeutics said Thursday they have entered into a collaboration to develop new small molecule medicines, starting with targets chosen by Incyte ( INCY ). The partnership will use Genesis' artificial intelligence platform, GEMS, to discover and improve small molecule compounds for the chosen targets. Incyte ( INCY...

PulteGroup Pilots Robotic-Assisted Wall Construction Process

Feb 20, 2025

11:35 AM EST, 02/20/2025 (MT Newswires) -- PulteGroup ( PHM ) said Thursday it built a home's structural walls using artificial intelligence and robotic technology in a test conducted in partnership with Australia's FBR. The homebuilder said it conducted the test using the Hadrian X system, which utilizes a robotic arm to precisely place concrete blocks that are secured using...